SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
----------
FORM 8-K
Current Report
Pursuant To Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (date of earliest event reported): October 20, 2003
E-Z-EM, INC.
(Exact Name of Registrant as Specified in its Charter)
Delaware
(State or Other Jurisdiction of Incorporation)
1-11479 11-1999504
(Commission File Number) (IRS Employer Identification No.)
1111 Marcus Avenue, Lake Success, New York 11042
(Address of Principal Executive Offices, Including Zip Code)
(516) 333-8230
(Registrant's Telephone Number, Including Area Code)
ITEM 5. OTHER EVENTS
On October 20, 2003, E-Z-EM, Inc., a Delaware corporation (the "Company"),
issued a press release announcing that the Company was considering a spin-off
and initial public offering of its wholly-owned subsidiary, AngioDynamics, Inc.,
based in Queensbury, N.Y.
A copy of the press release is attached hereto as Exhibit 99.1 and is
incorporated herein by reference.
ITEM 7. FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS
(c) Exhibits
Exhibit 99.1 Press Release dated October 20, 2003.
SIGNATURES:
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Dated: October 20, 2003 E-Z-EM, INC.
(Registrant)
By: /s/ Anthony A. Lombardo
--------------------------------
Anthony A. Lombardo
President and Chief Executive Officer